Zhi‐Nan Chen

17.5k total citations · 4 hit papers
349 papers, 11.2k citations indexed

About

Zhi‐Nan Chen is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Zhi‐Nan Chen has authored 349 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 234 papers in Molecular Biology, 114 papers in Immunology and 76 papers in Oncology. Recurrent topics in Zhi‐Nan Chen's work include Signaling Pathways in Disease (116 papers), Galectins and Cancer Biology (54 papers) and CAR-T cell therapy research (27 papers). Zhi‐Nan Chen is often cited by papers focused on Signaling Pathways in Disease (116 papers), Galectins and Cancer Biology (54 papers) and CAR-T cell therapy research (27 papers). Zhi‐Nan Chen collaborates with scholars based in China, United States and Hong Kong. Zhi‐Nan Chen's co-authors include Jian‐Li Jiang, Huijie Bian, Juan Tang, Jiao Wu, Jinliang Xing, Xuejun Jiang, Ping Zhu, Yunshan Guo, Yong Li and Minghui Gao and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Zhi‐Nan Chen

338 papers receiving 11.1k citations

Hit Papers

Intercellular interaction dictates cancer cell fer... 2014 2026 2018 2022 2019 2014 2022 2022 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhi‐Nan Chen China 55 7.2k 2.8k 2.7k 2.2k 1.6k 349 11.2k
Zhi Yao China 56 6.3k 0.9× 2.6k 0.9× 1.8k 0.7× 3.0k 1.3× 1.0k 0.6× 258 10.5k
Min‐Liang Kuo Taiwan 66 7.6k 1.1× 2.8k 1.0× 2.0k 0.7× 3.8k 1.7× 1.2k 0.7× 191 13.1k
Lukas Kenner Austria 52 5.1k 0.7× 1.5k 0.5× 2.2k 0.8× 3.0k 1.4× 920 0.6× 225 10.4k
Shuang Chen China 49 6.5k 0.9× 1.9k 0.7× 1.8k 0.7× 1.6k 0.7× 842 0.5× 428 11.1k
Li Li China 57 8.9k 1.2× 2.8k 1.0× 1.6k 0.6× 1.9k 0.9× 784 0.5× 493 13.6k
Xuehao Wang China 53 4.6k 0.6× 2.7k 1.0× 2.3k 0.9× 1.7k 0.8× 893 0.6× 239 9.3k
Jiří Zavadil United States 56 8.1k 1.1× 2.7k 1.0× 1.3k 0.5× 2.9k 1.3× 1.1k 0.7× 147 12.6k
Hong Zhao China 59 4.7k 0.7× 1.7k 0.6× 2.9k 1.1× 3.9k 1.7× 1.4k 0.9× 273 12.5k
Shahab Uddin Qatar 69 7.9k 1.1× 2.8k 1.0× 3.5k 1.3× 5.0k 2.3× 845 0.5× 385 15.1k
Xiao‐Ming Meng China 58 8.1k 1.1× 3.6k 1.3× 2.0k 0.7× 1.2k 0.5× 1.8k 1.1× 256 15.3k

Countries citing papers authored by Zhi‐Nan Chen

Since Specialization
Citations

This map shows the geographic impact of Zhi‐Nan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi‐Nan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi‐Nan Chen more than expected).

Fields of papers citing papers by Zhi‐Nan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhi‐Nan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi‐Nan Chen. The network helps show where Zhi‐Nan Chen may publish in the future.

Co-authorship network of co-authors of Zhi‐Nan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Zhi‐Nan Chen. A scholar is included among the top collaborators of Zhi‐Nan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhi‐Nan Chen. Zhi‐Nan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Peng, et al.. (2023). Configurations and Control Strategies of Hybrid Powertrain Systems. Energies. 16(2). 725–725. 9 indexed citations
3.
Wang, Hao, Xue Liang, Jing Fan, et al.. (2023). A four oxidative stress gene prognostic model and integrated immunity-analysis in pancreatic adenocarcinoma. Frontiers in Oncology. 12. 1015042–1015042. 13 indexed citations
4.
Wang, Yarong, Ying Shi, Xiaohong Chen, et al.. (2023). SETDB1-mediated CD147-K71 di-methylation promotes cell apoptosis in non-small cell lung cancer. Genes & Diseases. 11(2). 978–992. 12 indexed citations
5.
Shao, Jie, Renyu Zhang, Ling‐Min Kong, et al.. (2023). Large HBV Surface Protein-Induced Unfolded Protein Response Dynamically Regulates p27 Degradation in Hepatocellular Carcinoma Progression. International Journal of Molecular Sciences. 24(18). 13825–13825. 4 indexed citations
6.
Cui, Hong‐Yong, Wei Wei, Xin Fu, et al.. (2022). PDGFA‐associated protein 1 is a novel target of c‐Myc and contributes to colorectal cancer initiation and progression. Cancer Communications. 42(8). 750–767. 16 indexed citations
7.
Gao, Jian, et al.. (2022). TNF-α inhibitor ameliorates immune-related arthritis and pneumonitis in humanized mice. Frontiers in Immunology. 13. 955812–955812. 9 indexed citations
8.
Chen, Zhi‐Nan, et al.. (2022). An Optimized MPC Method for Restraining the Midpoint Voltage Fluctuation of 3-Level T-Type Grid-Connected Inverter. Journal of Electrical Engineering and Technology. 18(2). 1111–1122. 2 indexed citations
9.
Wu, Jiao, et al.. (2014). HAb18G/CD147 Promotes Radioresistance in Hepatocellular Carcinoma Cells: A Potential Role for Integrin β1 Signaling. Molecular Cancer Therapeutics. 14(2). 553–563. 48 indexed citations
10.
Zhang, Zheng, Yang Zhang, Qian Sun, et al.. (2014). Preclinical Pharmacokinetics, Tolerability, and Pharmacodynamics of Metuzumab, a Novel CD147 Human–Mouse Chimeric and Glycoengineered Antibody. Molecular Cancer Therapeutics. 14(1). 162–173. 29 indexed citations
11.
Kong, Ling‐Min, Cheng‐Gong Liao, Yang Zhang, et al.. (2014). A Regulatory Loop Involving miR-22, Sp1, and c-Myc Modulates CD147 Expression in Breast Cancer Invasion and Metastasis. Cancer Research. 74(14). 3764–3778. 138 indexed citations
12.
Li, Ling, Wenhua Tang, Xiaoqing Wu, et al.. (2013). HAb18G/CD147 Promotes pSTAT3-Mediated Pancreatic Cancer Development via CD44s. Clinical Cancer Research. 19(24). 6703–6715. 57 indexed citations
13.
Ding, Shifang, Qing Lü, Zhigang Gong, et al.. (2013). Changes of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinase-1 during left ventricular remodeling in acute myocardial infarctionpatients after percutaneous coronary intervention. Biomedical Research-tokyo. 24(2). 0. 1 indexed citations
14.
Xing, Jinliang, Shaogui Wan, Feng Zhou, et al.. (2012). Genetic Polymorphisms in Pre-microRNA Genes as Prognostic Markers of Colorectal Cancer. Cancer Epidemiology Biomarkers & Prevention. 21(1). 217–227. 72 indexed citations
15.
Wang, Longxin, Weihong Wen, Jianlin Yuan, et al.. (2009). Immunotherapy for Human Renal Cell Carcinoma by Adoptive Transfer of Autologous Transforming Growth Factor β–Insensitive CD8+ T Cells. Clinical Cancer Research. 16(1). 164–173. 35 indexed citations
16.
Xing, Jinliang, Jaffer A. Ajani, Meng Chen, et al.. (2009). Constitutive Short Telomere Length of Chromosome 17p and 12q but not 11q and 2p Is Associated with an Increased Risk for Esophageal Cancer. Cancer Prevention Research. 2(5). 459–465. 63 indexed citations
17.
Yang, Hushan, Jian Gu, Kenneth K. Wang, et al.. (2009). MicroRNA Expression Signatures in Barrett's Esophagus and Esophageal Adenocarcinoma. Clinical Cancer Research. 15(18). 5744–5752. 109 indexed citations
18.
Tao, Jie, et al.. (2009). Detection of pathogenic Verticillium spp. using matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry. Rapid Communications in Mass Spectrometry. 23(23). 3647–3654. 14 indexed citations
19.
Tang, Juan, Hongwei Zhou, Jian‐Li Jiang, et al.. (2007). BetaIg-h3 is involved in the HAb18G/CD147-mediated metastasis process in human hepatoma cells.. PubMed. 232(3). 344–52. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026